Omicron variant of SARS‐CoV‐2: genomics, transmissibility, and responses to current COVID‐19 vaccines
Currently, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has spread
worldwide as an Omicron variant. This variant is a heavily mutated virus and designated as …
worldwide as an Omicron variant. This variant is a heavily mutated virus and designated as …
Emergence of SARS-CoV-2 Omicron (B. 1.1. 529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Since the appearance in the late of December 2019, SARS-CoV-2 is rapidly evolving and
mutating continuously, giving rise to various variants with variable degrees of infectivity and …
mutating continuously, giving rise to various variants with variable degrees of infectivity and …
A detailed overview of immune escape, antibody escape, partial vaccine escape of SARS-CoV-2 and their emerging variants with escape mutations
The infective SARS-CoV-2 is more prone to immune escape. Presently, the significant
variants of SARS-CoV-2 are emerging in due course of time with substantial mutations …
variants of SARS-CoV-2 are emerging in due course of time with substantial mutations …
[HTML][HTML] Omicron (B. 1.1. 529) variant of SARS‐CoV‐2: concerns, challenges, and recent updates
Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
The puzzling mutational landscape of the SARS‐2‐variant Omicron
The recently emerging SARS‐CoV‐2 variant omicron displays an unusual association of 30
mutations, 3 deletions, and 1 insertion. To analyze the impact of this atypic mutational …
mutations, 3 deletions, and 1 insertion. To analyze the impact of this atypic mutational …
Effect of molnupiravir on biomarkers, respiratory interventions, and medical services in COVID-19: a randomized, placebo-controlled trial
MG Johnson, A Puenpatom, PA Moncada… - Annals of internal …, 2022 - acpjournals.org
Background: In the MOVe-OUT trial, molnupiravir showed a clinically meaningful reduction
in the risk for hospitalization or death in adults with mild to moderate COVID-19 and risk …
in the risk for hospitalization or death in adults with mild to moderate COVID-19 and risk …
[HTML][HTML] Omicron variant: Current insights and future directions
R Rana, R Kant, RS Huirem, D Bohra… - Microbiological …, 2022 - Elsevier
The global COVID-19 outbreak has returned with the identification of the SARS-CoV-2
Omicron variant (B. 1.1. 529) after appearing to be persistently spreading for the more than …
Omicron variant (B. 1.1. 529) after appearing to be persistently spreading for the more than …
COVID-19 and vaccination: myths vs science
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …
Antibody titers and protection against Omicron (BA. 1 and BA. 2) SARS-CoV-2 infection
C Dimeglio, M Migueres, N Bouzid, S Chapuy-Regaud… - Vaccines, 2022 - mdpi.com
The emergence of the SARS-CoV-2 variants of concern has greatly influenced the immune
correlates of protection, and there are little data about the antibody threshold concentrations …
correlates of protection, and there are little data about the antibody threshold concentrations …
Tracking and controlling the spatiotemporal spread of SARS-CoV-2 Omicron variant in South Africa
Abstract Background South Africa is the focus of the current epidemic caused by Omicron.
Understanding the spatiotemporal spread of Omicron in South Africa and how to control it is …
Understanding the spatiotemporal spread of Omicron in South Africa and how to control it is …